CClinicalTrials.gg
CompletedNCT06444958Updated Jun 6, 2024

Morbidity and Mortality Rates Among Children Aged 0-59 Months

An observational study in Morbidity;Infant, sponsored by Kalkaal Hospital. Completed at 1 site in Somalia. Open to participants aged 0 Months to 59 Months. Per ClinicalTrials.gov, last updated 2024-06-06.

Sponsored by Kalkaal Hospital · Observational

Study type
Observational
Model
Case-only
Time perspective
Retrospective
Enrollment
1,675
Ages
0 Months to 59 Months
Sex
All
01

Study summary

This retrospective observational study aimed to investigate the patterns of morbidity and mortality among children under 5 years of age in the population served by Kalkaal Hospital. Researchers analyzed 2023 data from the hospital's electronic medical records and administrative databases to identify the most common pediatric diagnoses and causes of illness and death in this community.

Read the detailed description

This study investigated the patterns of morbidity and mortality among children under 5 years of age in the population served by Kalkaal Hospital. The specific objectives were to:

Identify the most common diagnoses and causes of illness and death in the under-5 population presenting to Kalkaal Hospital.

Analyze demographic factors (e.g. age, sex) associated with certain disease profiles and health outcomes.

Evaluate treatment practices, health service utilization, and mortality rates for the key pediatric health issues identified.

Provide a comprehensive epidemiological assessment of the burden of childhood illness and mortality in this local community.

Methods:

This was a retrospective, observational study that analyzed 2023 data from the electronic medical records and administrative databases of Kalkaal Hospital. The researchers extracted and analyzed the following data:

Outpatient department records: Diagnoses, treatments, patient demographics Inpatient admission records: Admission diagnoses, treatments, patient outcomes (discharged, transferred, died) Mortality records: Causes of death for pediatric patients The data was cleaned, coded, and analyzed using statistical software. Descriptive statistics were calculated to characterize the morbidity and mortality patterns. Regression analyses were conducted to identify demographic and clinical factors associated with key health outcomes.

02

Conditions studied

  • Morbidity;Infant
03

In context

Lead sponsor

This is the only study on the registry with Kalkaal Hospital as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
0 Months to 59 Months
Sexes eligible
All
Sampling method
Probability sample

Study population

Children under 5 years of age in the population served by Kalkaal Hospital

The target population was the pediatric patients under the age of 5 who accessed healthcare services at Kalkaal Hospital.

The researchers extracted data from the hospital's records on all children under 5 who presented as outpatients, were admitted as inpatients, or were recorded in the mortality database.

Inclusion criteria

  1. Children aged 0-59 months who were admitted to Kalkaal Hospital during the specified study period.
  2. Medical records with complete and adequate information regarding age, gender, presenting symptoms, and diagnoses.

Exclusion criteria

-

Exclusion Criteria:

  1. Children outside the age range of 0-59 months.
  2. Medical records with missing or incomplete information necessary for the analysis.
  3. Children admitted to Kalkaal Hospital for reasons unrelated to the study objectives (adult patients, non-pediatric cases).
05

Study design

Observational model
Case-only
Time perspective
Retrospective
Enrollment
1,675 participants (actual)
Patient registry
No

Interventions

  • Diagnostic testobservational study without any intervention component.

    extracting and analyzing the following data: Outpatient department records: Diagnoses, treatments, patient demographics Inpatient admission records: Admission diagnoses, treatments, patient outcomes (discharged, transferred, died) Mortality records: Causes of death for pediatric patients

06

What researchers measure

Primary outcomes

  1. Incidence Rate of Morbidities: Incidence rates of various morbidities among children presenting to the outpatient department and inpatient wards.

    This outcome measure will calculate the incidence rates of various morbidities among children under 18 years of age who presented to the Kalkaal Hospital outpatient department or were admitted to the inpatient wards during the 5-year study period (2018-2022). The incidence rates will be reported for the top 10 most common morbidities observed in the study population.

    Time frame: JANUARY-DECEMBER 2023

  2. Mortality Rate by Age Group: Mortality rates and associated risk factors across different age groups of children under 18 (under 28 days, 29-365 days, 1-5 years).

    This outcome measure will determine the mortality rates among children under 18 years of age treated at Kalkaal Hospital, stratified by the following age groups: under 28 days, 29-365 days, and 1-5 years. The analysis will also identify risk factors associated with mortality in each age group.

    Time frame: JANUARY-DECEMBER 2023

  3. Average Length of Hospital Stay: Median hospital stay duration for children under 18 years old.

    This outcome measure will calculate the median length of hospital stay for children under 18 years old who were admitted to the Kalkaal Hospital inpatient wards during the study period. The average length of stay will be reported overall, as well as by primary diagnosis categories.

    Time frame: JANUARY-DECEMBER 2023

07

Study locations

1 site
  • Kalkaal Hospital
    Mogadishu, Banadir +252, Somalia
08

References and documents

Individual participant data

Plan to share: Undecided — Data Sharing Plan: The de-identified individual patient data (IPD) collected and analyzed for this retrospective observational study on pediatric morbidity and mortality at Kalkaal Hospital will be made available to other researchers upon reasonable request.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 6, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06444958
Lead sponsor
Kalkaal Hospital
Responsible party
Sponsor
First posted
Jun 6, 2024
Start date
Jan 1, 2023
Primary completion
Dec 15, 2023
Completion
Dec 15, 2023
Last update
Jun 6, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion